[
  {
    "ts": null,
    "headline": "Waters price target raised to $375 from $370 at BofA",
    "summary": "BofA analyst Michael Ryskin raised the firm’s price target on Waters (WAT) to $375 from $370 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools",
    "url": "https://finnhub.io/api/news?id=b882f0fdcec1fdd75de5b50cc4bdd8fee54ca6e9e0add54215b18c761d103caa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751034370,
      "headline": "Waters price target raised to $375 from $370 at BofA",
      "id": 135600504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "BofA analyst Michael Ryskin raised the firm’s price target on Waters (WAT) to $375 from $370 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools",
      "url": "https://finnhub.io/api/news?id=b882f0fdcec1fdd75de5b50cc4bdd8fee54ca6e9e0add54215b18c761d103caa"
    }
  }
]